Search Results for "hansten"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for hansten. Results 121 to 130 of 433 total matches.

Botulinum Toxin (Botox) for Axillary Hyperhidrosis

   
The Medical Letter on Drugs and Therapeutics • Sep 13, 2004  (Issue 1191)
: Martin A. Rizack, M.D., Ph.D., Rockefeller University ADVISORY BOARD: Philip D. Hansten, Pharm. D ...
Botulinum toxin type A (Botox - Allergan) has been approved by the FDA for treatment of severe underarm sweating ("primary axillary hyperhidrosis"). Injected into the skin, botulinum toxin decreases sweating by causing chemical denervation of the sweat gland.
Med Lett Drugs Ther. 2004 Sep 13;46(1191):76 |  Show IntroductionHide Introduction

Cinacalcet (Sensipar)

   
The Medical Letter on Drugs and Therapeutics • Sep 20, 2004  (Issue 1192)
University ADVISORY BOARD: Philip D. Hansten, Pharm. D., University of Washington Jules Hirsch, M.D ...
Cinacalcet hydrochloride (Sensipar - Amgen) has been approved by the FDA for treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease on dialysis and treatment of hypercalcemia in patients with parathyroid carcinoma.
Med Lett Drugs Ther. 2004 Sep 20;46(1192):80 |  Show IntroductionHide Introduction

Parcopa: A Rapidly Dissolving Formulation of Carbidopa/Levodopa

   
The Medical Letter on Drugs and Therapeutics • Jan 31, 2005  (Issue 1201)
., Rockefeller University ADVISORY BOARD: Philip D. Hansten, Pharm. D., University of Washington Jules Hirsch ...
An orally dissolving, immediate-release tablet formulation of carbidopa/levodopa (Parcopa - Schwarz) that can be taken without water is now available for treatment of Parkinson's disease.
Med Lett Drugs Ther. 2005 Jan 31;47(1201):12 |  Show IntroductionHide Introduction

Albumin-Bound Paclitaxel (Abraxane) for Advanced Breast Cancer

   
The Medical Letter on Drugs and Therapeutics • May 09, 2005  (Issue 1208)
. Hansten, Pharm. D., University of Washington Jules Hirsch, M.D., Rockefeller University James D. Kenney ...
A new albumin-bound formulation of paclitaxel (Abraxane - American Pharmaceutical Partners) has been approved by the FDA for treatment of metastatic breast cancer after failure of combination chemotherapy or relapse within 6 months of adjuvant chemotherapy. This formulation is free of polyoxyethylated castor oil (Cremophor), a solvent thought to contribute to the hypersensitivity reactions that occur frequently with standard paclitaxel (Taxol, and others) and are severe in about 3% of patients.
Med Lett Drugs Ther. 2005 May 9;47(1208):39-40 |  Show IntroductionHide Introduction

In Brief: Toxicity of Gadolinium-Based Contrast Agents

   
The Medical Letter on Drugs and Therapeutics • Jun 04, 2007  (Issue 1262)
. Hansten, Pharm.D., University of Washington ADVISORY BOARD: Jules Hirsch, M.D., Rockefeller University ...
Gadolinium-based contrast agents, which are used mainly for magnetic resonance imaging and angiography, were first introduced partly because of the discovery in the 1990’s that iodine-based contrast agents could cause nephrotoxicity and acute renal failure. Some recent reports have suggested, however, that gadolinium-based agents may also be nephrotoxic.1 One patient who developed acute renal failure after use of gadolinium-based contrast had a renal biopsy that showed acute tubular injury.2Moreover, after exposure to gadolinium-based contrast, some patients with severe renal insufficiency,...
Med Lett Drugs Ther. 2007 Jun 4;49(1262):45 |  Show IntroductionHide Introduction

Addendum: Warfarin-Acetaminophen Interaction

   
The Medical Letter on Drugs and Therapeutics • Jun 16, 2008  (Issue 1288)
INTERACTIONS: Philip D. Hansten, Pharm.D.,University of Washington ADVISORY BOARD: Jules Hirsch, M.D ...
A reader expressed disappointment that our recent listing of “Some Warfarin Drug Interactions”1 did not include acetaminophen. Perhaps it should have. Acetaminophen can increase the anticoagulant effect of warfarin, particularly with continued use, but it does so inconsistently. The mechanism of this interaction has not been established, but may be related to an acetaminophen metabolite inhibiting vitamin K-epoxide reductase, the target for warfarin’s anticoagulant effect.2Patient susceptibility varies, possibly on a genetic basis; occasional use of acetaminophen generally has little or...
Med Lett Drugs Ther. 2008 Jun 16;50(1288):45 |  Show IntroductionHide Introduction

Varenicline (Chantix) Warnings: Risk Versus Benefit

   
The Medical Letter on Drugs and Therapeutics • Jul 14, 2008  (Issue 1290)
INTERACTIONS: Philip D. Hansten, Pharm.D., University of Washington ADVISORY BOARD: Jules Hirsch, M.D ...
The nicotine receptor partial agonist varenicline (Chantix - Pfizer) appears to be the most effective drug available to treat tobacco dependence, but the FDA has added a warning to the package insert about neuropsychiatric symptoms and exacerbations of preexisting psychiatric illness associated with its use. Agitation, hostility, depressed mood, suicidal ideation and suicidal behavior have been reported as postmarketing adverse events in patients who took varenicline and stopped smoking and in those who took the drug and continued to smoke.
Med Lett Drugs Ther. 2008 Jul 14;50(1290):53 |  Show IntroductionHide Introduction

ECGs Before Stimulants in Children

   
The Medical Letter on Drugs and Therapeutics • Jul 28, 2008  (Issue 1291)
INTERACTIONS: Philip D. Hansten, Pharm.D., University of Washington ADVISORY BOARD: Jules Hirsch, M.D ...
The American Heart Association (AHA) recently published a statement saying that it would be reasonable to obtain an electrocardiogram (ECG) in children being evaluated for stimulant drug therapy for attention deficit hyperactivity disorder (ADHD). A subsequent news release in conjunction with the American Academy of Pediatrics provided a clarification, saying that it would be reasonable to consider obtaining an ECG in such children.
Med Lett Drugs Ther. 2008 Jul 28;50(1291):60 |  Show IntroductionHide Introduction

Zingo for Local Analgesia in Children

   
The Medical Letter on Drugs and Therapeutics • Aug 25, 2008  (Issue 1293)
CONTRIBUTING EDITOR, DRUG INTERACTIONS: Philip D. Hansten, Pharm.D., University of Washington ADVISORY BOARD ...
The FDA has approved the marketing of a new device for delivering lidocaine to the skin of children undergoing a venipuncture or intravenous (IV) line placement. Zingo (Anesiva) is a powder intradermal injection system.
Med Lett Drugs Ther. 2008 Aug 25;50(1293):68 |  Show IntroductionHide Introduction

In Brief: Melamine

   
The Medical Letter on Drugs and Therapeutics • Oct 20, 2008  (Issue 1297)
Einstein College of Medicine CONTRIBUTING EDITOR, DRUG INTERACTIONS: Philip D. Hansten, Pharm.D ...
Melamine present in infant formula and other milk products has been associated with widespread illness and some deaths among infants in China. It was also identified in pet food sold in North America after a large number of pets became ill and some died. In both the infants and the pets, renal injury appeared to be the cause.1Melamine (C3H6N6) is a heterocyclic compound, two-thirds nitrogen by weight, that is slightly soluble in water. When combined with formaldehyde, it forms melamine resin, which has a wide variety of industrial applications including the manufacturing of kitchenware,...
Med Lett Drugs Ther. 2008 Oct 20;50(1297):81 |  Show IntroductionHide Introduction